Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tavaborole

A topical antifungal of the oxaborole class, the first boron-based antifungal approved by the FDA, in 2014. It is a 5% solution for toenail onychomycosis, caused mainly by the dermatophytes Trichophyton rubrum and Trichophyton mentagrophytes. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It blocks the fungus's leucyl-tRNA synthetase by trapping transfer RNA in the enzyme's editing site, so the fungus can no longer make proteins. Its small size helps it penetrate the nail.

TavaboroleGo to the active ingredient →
TavaboroleActive ingredientTavaboroleCat. No. P-T022-001CAS 174671-46-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.